Medici: Investor Relations Activity Record Form (2024 Semi-Annual Science and Technology Innovation Board Pharmaceutical and Biological Products Group Performance Briefing)
Medici: Announcement on participating in the 2024 Semi-Annual Science and Technology Innovation Board Special Group Performance Briefing on Pharmaceuticals and Biological Products
Guangfa Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Shanghai Medici Biomedical Co., Ltd.
Shanghai Medicilon Inc.: Investor Relations Activity Record (2024-08-001)
GF SEC's verification opinion on Shanghai Medicilon Inc. using part of the idle raised funds for cash management.
Shanghai Medicilon Inc.: Announcement regarding the use of temporarily idle funds raised for cash management.
Shanghai Medicilon Inc.: Half-year evaluation report of the "Quality Improvement and Efficiency Increase for Return" action plan for the year 2024.
Shanghai Medicilon Inc.: Special report on the use and placement of funds raised during the first half of 2024.
Shanghai Medicilon Inc.: Announcement of the Resolution of the 20th Meeting of the 3rd Supervisory Board.
Shanghai Medicilon Inc.: Investor relations activity record (2024-07-002)
Shanghai Medicilon Inc.: Investor Relations Activity Record Form (2024-07-001)
Reply to the regulatory inquiry letter on information disclosure of the annual report of Shanghai Medicilon Inc. for the year 2023 by Ruihua Certified Public Accountants (Special General Partnership).
Shanghai Medicilon Inc.: Investor Relations Activity Record Form (2024-05-001)
Shanghai Medicilon Inc.: Announcement on holding the results briefing for the first quarter of 2023 and 2024
GF Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Shanghai Medici Biomedical Co., Ltd.
Shanghai Medicilon Inc.: Investor Relations Activity Record Form (2024-04-001)
Shanghai Medicilon Inc.: Announcement of Resolutions of the 21st Meeting of the Third Board of Directors
Medici: 2023 Social Responsibility Report
Medici: 2023 Internal Control Audit Report
Medici: Performance Evaluation Report on Lixin Certified Public Accountants (Special General Partnership)
No Data
No Data